Corvas presents 3-D molecular structure of matriptase, first structural insight into new class of protease cancer targets
Scientists have solved the three-dimensional molecular structure of matriptase, a newly identified serine protease target for breast and prostate cancer drug development. This structural information is expected to facilitate the design of drugs that block or exploit the activity of matriptase and related proteases.